Trial Profile
A Phase I, Single Center, Open Label, Randomized, Single-Dose, Three-Way Crossover Study to Compare the Pharmacokinetics and Bioavailability of Two NP101 (Sumatriptan Iontophoretic Transdermal Patch) With an Oral Formulation of Imitrex in Healthy Volunteers and to Collect Resistance Data During Application of NP101.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2020
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary) ; Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors NuPathe
- 29 Jun 2011 New trial record